Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jason Glanz and Bruce Fireman.
Jason Glanz
Connection Strength
1.173
Bruce Fireman
  1. A primer on quantitative bias analysis with positive predictive values in research using electronic health data. J Am Med Inform Assoc. 2019 12 01; 26(12):1664-1674.
    View in: PubMed
    Score: 0.176
  2. Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule. Vaccine. 2019 Feb 28; 37(10):1325-1331.
    View in: PubMed
    Score: 0.166
  3. Bias from outcome misclassification in immunization schedule safety research. Pharmacoepidemiol Drug Saf. 2018 Feb; 27(2):221-228.
    View in: PubMed
    Score: 0.155
  4. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012 May; 129(5):809-14.
    View in: PubMed
    Score: 0.104
  5. Mortality risk after COVID-19 vaccination: A self-controlled case series study. Vaccine. 2024 Mar 07; 42(7):1731-1737.
    View in: PubMed
    Score: 0.059
  6. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting. Ann Intern Med. 2024 Jan 09.
    View in: PubMed
    Score: 0.059
  7. A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. Vaccine. 2023 01 16; 41(3):844-854.
    View in: PubMed
    Score: 0.054
  8. Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. Vaccine. 2022 08 19; 40(35):5153-5159.
    View in: PubMed
    Score: 0.053
  9. Safety of COVID-19 Vaccination in US Children Ages 5-11 Years. Pediatrics. 2022 May 18.
    View in: PubMed
    Score: 0.052
  10. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Netw Open. 2022 04 01; 5(4):e228879.
    View in: PubMed
    Score: 0.052
  11. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 Sep 03.
    View in: PubMed
    Score: 0.050
  12. COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 16; 70(28):985-990.
    View in: PubMed
    Score: 0.049
  13. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065.
    View in: PubMed
    Score: 0.047
  14. Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines. Pharmacoepidemiol Drug Saf. 2018 Apr; 27(4):405-412.
    View in: PubMed
    Score: 0.039
  15. Risk factors and familial clustering for fever 7-10days after the first dose of measles vaccines. Vaccine. 2017 03 14; 35(12):1615-1621.
    View in: PubMed
    Score: 0.036
  16. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010 Jan 15; 171(2):177-88.
    View in: PubMed
    Score: 0.022

© 2024 Kaiser Permanente